Cargando…

The Impact of Delayed Symptomatic Treatment Implementation in the Intensive Care Unit

We estimated the harm related to medication delivery delays across 12,474 medication administration instances in an intensive care unit using retrospective data in a large urban academic medical center between 2012 and 2015. We leveraged an instrumental variables (IV) approach that addresses unobser...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Lesley, Laudanski, Krzysztof, Restrepo, Mariana, Huffenberger, Ann, Terwiesch, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774917/
https://www.ncbi.nlm.nih.gov/pubmed/35052199
http://dx.doi.org/10.3390/healthcare10010035
_version_ 1784636458164813824
author Meng, Lesley
Laudanski, Krzysztof
Restrepo, Mariana
Huffenberger, Ann
Terwiesch, Christian
author_facet Meng, Lesley
Laudanski, Krzysztof
Restrepo, Mariana
Huffenberger, Ann
Terwiesch, Christian
author_sort Meng, Lesley
collection PubMed
description We estimated the harm related to medication delivery delays across 12,474 medication administration instances in an intensive care unit using retrospective data in a large urban academic medical center between 2012 and 2015. We leveraged an instrumental variables (IV) approach that addresses unobserved confounds in this setting. We focused on nurse shift changes as disruptors of timely medication (vasodilators, antipyretics, and bronchodilators) delivery to estimate the impact of delay. The average delay around a nurse shift change was 60.8 min (p < 0.001) for antipyretics, 39.5 min (p < 0.001) for bronchodilators, and 57.1 min (p < 0.001) for vasodilators. This delay can increase the odds of developing a fever by 32.94%, tachypnea by 79.5%, and hypertension by 134%, respectively. Compared to estimates generated by a naïve regression approach, our IV estimates tend to be higher, suggesting the existence of a bias from providers prioritizing more critical patients.
format Online
Article
Text
id pubmed-8774917
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87749172022-01-21 The Impact of Delayed Symptomatic Treatment Implementation in the Intensive Care Unit Meng, Lesley Laudanski, Krzysztof Restrepo, Mariana Huffenberger, Ann Terwiesch, Christian Healthcare (Basel) Article We estimated the harm related to medication delivery delays across 12,474 medication administration instances in an intensive care unit using retrospective data in a large urban academic medical center between 2012 and 2015. We leveraged an instrumental variables (IV) approach that addresses unobserved confounds in this setting. We focused on nurse shift changes as disruptors of timely medication (vasodilators, antipyretics, and bronchodilators) delivery to estimate the impact of delay. The average delay around a nurse shift change was 60.8 min (p < 0.001) for antipyretics, 39.5 min (p < 0.001) for bronchodilators, and 57.1 min (p < 0.001) for vasodilators. This delay can increase the odds of developing a fever by 32.94%, tachypnea by 79.5%, and hypertension by 134%, respectively. Compared to estimates generated by a naïve regression approach, our IV estimates tend to be higher, suggesting the existence of a bias from providers prioritizing more critical patients. MDPI 2021-12-25 /pmc/articles/PMC8774917/ /pubmed/35052199 http://dx.doi.org/10.3390/healthcare10010035 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Meng, Lesley
Laudanski, Krzysztof
Restrepo, Mariana
Huffenberger, Ann
Terwiesch, Christian
The Impact of Delayed Symptomatic Treatment Implementation in the Intensive Care Unit
title The Impact of Delayed Symptomatic Treatment Implementation in the Intensive Care Unit
title_full The Impact of Delayed Symptomatic Treatment Implementation in the Intensive Care Unit
title_fullStr The Impact of Delayed Symptomatic Treatment Implementation in the Intensive Care Unit
title_full_unstemmed The Impact of Delayed Symptomatic Treatment Implementation in the Intensive Care Unit
title_short The Impact of Delayed Symptomatic Treatment Implementation in the Intensive Care Unit
title_sort impact of delayed symptomatic treatment implementation in the intensive care unit
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774917/
https://www.ncbi.nlm.nih.gov/pubmed/35052199
http://dx.doi.org/10.3390/healthcare10010035
work_keys_str_mv AT menglesley theimpactofdelayedsymptomatictreatmentimplementationintheintensivecareunit
AT laudanskikrzysztof theimpactofdelayedsymptomatictreatmentimplementationintheintensivecareunit
AT restrepomariana theimpactofdelayedsymptomatictreatmentimplementationintheintensivecareunit
AT huffenbergerann theimpactofdelayedsymptomatictreatmentimplementationintheintensivecareunit
AT terwieschchristian theimpactofdelayedsymptomatictreatmentimplementationintheintensivecareunit
AT menglesley impactofdelayedsymptomatictreatmentimplementationintheintensivecareunit
AT laudanskikrzysztof impactofdelayedsymptomatictreatmentimplementationintheintensivecareunit
AT restrepomariana impactofdelayedsymptomatictreatmentimplementationintheintensivecareunit
AT huffenbergerann impactofdelayedsymptomatictreatmentimplementationintheintensivecareunit
AT terwieschchristian impactofdelayedsymptomatictreatmentimplementationintheintensivecareunit